In addition to inflammatory joint diseases, increased levels of YKL-40 have been found in other diseases characterized by inflammation and tissue remodeling like asthma, COPD, liver fibrosis, and cancer [1,27]. This evidence concerns the gene CHI3L1 and chronic obstructive pulmonary disease.